Annual EBIT
-$83.05 M
-$29.20 M-54.24%
December 31, 2023
Summary
- As of February 10, 2025, RPHM annual earnings before interest & taxes is -$83.05 million, with the most recent change of -$29.20 million (-54.24%) on December 31, 2023.
- During the last 3 years, RPHM annual EBIT has fallen by -$63.50 million (-324.78%).
Performance
RPHM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBIT
-$6.36 M
+$3.20 M+33.46%
June 30, 2024
Summary
- As of February 10, 2025, RPHM quarterly earnings before interest & taxes is -$6.36 million, with the most recent change of +$3.20 million (+33.46%) on June 30, 2024.
- Over the past year, RPHM quarterly EBIT has increased by +$18.64 million (+74.55%).
Performance
RPHM Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBIT
-$61.82 M
+$14.68 M+19.18%
June 30, 2024
Summary
- As of February 10, 2025, RPHM TTM earnings before interest & taxes is -$61.82 million, with the most recent change of +$14.68 million (+19.18%) on June 30, 2024.
- Over the past year, RPHM TTM EBIT has increased by +$21.23 million (+25.57%).
Performance
RPHM TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
RPHM EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -54.2% | +74.5% | +25.6% |
| 3 y3 years | -324.8% | +48.8% | -26.6% |
| 5 y5 years | -436.8% | +11.8% | -177.7% |
RPHM EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +108.6% | at low | at high | +292.9% | +55.3% | +34.3% |
| 5 y | 5-year | +436.8% | at low | +72.0% | +292.9% | +1273.2% | +34.3% |
| alltime | all time | +436.8% | at low | +72.0% | +292.9% | +1273.2% | +34.3% |
Reneo Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | - | -$6.36 M(-33.5%) | -$61.82 M(-19.2%) |
| Mar 2024 | - | -$9.56 M(-61.8%) | -$76.50 M(-7.9%) |
| Dec 2023 | -$83.05 M(+54.2%) | -$25.01 M(+19.7%) | -$83.06 M(+14.4%) |
| Sep 2023 | - | -$20.89 M(-0.7%) | -$72.61 M(+10.7%) |
| Jun 2023 | - | -$21.04 M(+30.5%) | -$65.56 M(+15.1%) |
| Mar 2023 | - | -$16.12 M(+10.7%) | -$56.96 M(+5.8%) |
| Dec 2022 | -$53.85 M(+35.2%) | -$14.56 M(+5.2%) | -$53.85 M(+7.9%) |
| Sep 2022 | - | -$13.84 M(+11.3%) | -$49.91 M(+2.2%) |
| Jun 2022 | - | -$12.43 M(-4.5%) | -$48.82 M(+7.0%) |
| Mar 2022 | - | -$13.02 M(+22.5%) | -$45.62 M(+14.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$39.82 M(+103.7%) | -$10.62 M(-16.7%) | -$39.82 M(+12.3%) |
| Sep 2021 | - | -$12.75 M(+38.2%) | -$35.45 M(+27.5%) |
| Jun 2021 | - | -$9.23 M(+27.9%) | -$27.79 M(+24.8%) |
| Mar 2021 | - | -$7.21 M(+15.4%) | -$22.26 M(+13.9%) |
| Dec 2020 | -$19.55 M(+26.4%) | - | - |
| Dec 2020 | - | -$6.25 M(+22.6%) | -$19.55 M(+47.0%) |
| Sep 2020 | - | -$5.10 M(+37.8%) | -$13.30 M(+62.2%) |
| Jun 2020 | - | -$3.70 M(-17.8%) | -$8.20 M(+82.2%) |
| Mar 2020 | - | -$4.50 M | -$4.50 M |
| Dec 2019 | -$15.47 M | - | - |
FAQ
- What is Reneo Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Reneo Pharmaceuticals?
- What is Reneo Pharmaceuticals annual EBIT year-on-year change?
- What is Reneo Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Reneo Pharmaceuticals?
- What is Reneo Pharmaceuticals quarterly EBIT year-on-year change?
- What is Reneo Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Reneo Pharmaceuticals?
- What is Reneo Pharmaceuticals TTM EBIT year-on-year change?
What is Reneo Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of RPHM is -$83.05 M
What is the all time high annual EBIT for Reneo Pharmaceuticals?
Reneo Pharmaceuticals all-time high annual earnings before interest & taxes is -$15.47 M
What is Reneo Pharmaceuticals annual EBIT year-on-year change?
Over the past year, RPHM annual earnings before interest & taxes has changed by -$29.20 M (-54.24%)
What is Reneo Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of RPHM is -$6.36 M
What is the all time high quarterly EBIT for Reneo Pharmaceuticals?
Reneo Pharmaceuticals all-time high quarterly earnings before interest & taxes is -$3.70 M
What is Reneo Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, RPHM quarterly earnings before interest & taxes has changed by +$18.64 M (+74.55%)
What is Reneo Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of RPHM is -$61.82 M
What is the all time high TTM EBIT for Reneo Pharmaceuticals?
Reneo Pharmaceuticals all-time high TTM earnings before interest & taxes is -$4.50 M
What is Reneo Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, RPHM TTM earnings before interest & taxes has changed by +$21.23 M (+25.57%)